Table 3 Peak look duration (ms) to each AOI type, by risk and outcome group
| Â | Â | Low risk | High risk | ||
|---|---|---|---|---|---|
| Â | Â | Â | Combineda | HR-no ASD | HR-ASD |
Face stimuli | 9Â months | 1916.29 (949.37) | 1931.74 (1238.49) | 1976.76 (1266.72) | 1845.04 (1161.71) |
|  | 270–3909 | 352–7516 | 352–7516 | 395–4051 | |
N | 23 | 94 | 76 | 16 | |
15Â months | 1132.13 (810.70) | 1771.72 (893.52) | 1750.02 (878.59) | 1916.50 (1082.76) | |
|  | 310–3950 | 448–5404 | 448–5404 | 760–4200 | |
N | 19 | 97 | 80 | 14 | |
Scrambled face stimuli | 9Â months | 868.35 (459.49) | 758.59 (343.26) | 759.18 (289.66) | 794.80 (535.53) |
|  | 260–2664 | 268–2736 | 268–1876 | 400–2736 | |
N | 22 | 93 | 74 | 17 | |
15Â months | 713.62 (334.68) | 643.82 (289.75) | 632.15 (298.15) | 676.51 (229.86) | |
|  | 380–1632 | 200–2572 | 284–2572 | 200–1152 | |
N | 20 | 94 | 78 | 13 | |
Difference score | − 195.70 (657.01) | − 71.68 (352.93) | − 91.47 (364.37) | 0.21 (309.93) | |
|  | − 2097–860 | − 1161–1068 | − 1161–1068 | − 555–517 | |
N | 16 | 75 | 60 | 13 | |
Non-social stimuli | 9Â months | 1319.12 (528.86) | 1250.52 (462.82) | 1229.39 (460.22) | 1320.63 (509.15) |
|  | 769–3018 | 280–2989 | 280–2989 | 651–2824 | |
N | 23 | 99 | 80 | 17 | |
15Â months | 1292.07 (664.91) | 1367.62 (628.25) | 1367.07 (675.84) | 1387.40 (268.22) | |
|  | 385–2949 | 420–3987 | 420–3987 | 894–1870 | |
N | 23 | 105 | 87 | 15 | |
Difference score | − 91.70 (798.14) | 72.27 (687.81) | 87.96 (712.65) | 49.76 (608.69) | |
|  | − 1243–1573 | − 1930–2697 | − 1405–2697 | − 1930–560 | |
N | 20 | 90 | 73 | 15 | |